Strategy and Design of In Situ Activated Protein Hydrolysis Targeted Chimeras

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Traditional small molecule inhibitors face challenges with "undruggable" targets and acquired resistance.
• Protein hydrolysis targeted chimeras (PROTACs) harness the ubiquitin-proteasome system for targeted protein degradation.
• PROTACs offer a cyclical, potent, and selective approach to protein degradation.

Purpose of the Study:

• To review strategies for stimuli-activated PROTACs for enhanced targeted protein degradation.
• To highlight key compounds and research advancements in activated PROTACs.
• To guide future exploration in the field of activated PROTACs.

Main Methods:

• Review of existing literature on stimuli-activated PROTACs.
• Analysis of various mechanisms of action for in situ activated PROTACs.
• Identification of key compounds and research progress.

Main Results:

• Stimuli-activated PROTACs improve degradation precision in time and space.
• These advanced PROTACs minimize off-target toxicity and harm to healthy cells.
• Various strategies and mechanisms for in situ activation have been developed.

Conclusions:

• Activated PROTACs represent a significant advancement in targeted protein degradation therapies.
• Further research into activated PROTACs holds promise for overcoming limitations of traditional inhibitors.
• The development of precise and safe PROTAC-based therapeutics is an active area of research.